Medical devices, healthcare technology and the business of care
510(k) clearance · K260115

DRIM-Nail System

41Medical AG · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK260115

What did the FDA decide?

The FDA's 510(k) database records K260115 for the DRIM-Nail System, submitted by 41Medical AG of Bettlach, Switzerland, with Alfred Niederberger listed as applicant contact and Mcra, LLC as correspondent. The record shows a receipt date of 01/14/2026 and a decision date of 09/11/2026, with the review panel listed as Orthopedic and the submission type as Traditional.

The decision is Substantially Equivalent (SESE), which is a 510(k) clearance rather than a premarket approval. The record states the device was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan. The specialty field is recorded as Unknown, and the available material does not describe the device's components, materials, indications for use, or predicate devices, so those details remain unverified here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260115
Regulatory pathway
510(k) premarket notification
Applicant
41Medical AG
Product code
Not reported
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

Applicant
41Medical AG
Product code
Not reported

FDA decision timeline

  1. K260115 received

    Application receipt date recorded by FDA.

  2. K260115 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

41Medical AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Bettlach

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records